AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15209605
Drug: Amantadine 100
RxNorm normalized name: amantadine 100 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amantadine 100 mg twice daily for 12 months
Trial: 11270027
Drug: 1.0 mL
RxNorm normalized name: digoxin 0.25 mg in 1.0 mL INTRAVENOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mL 0.9% saline (Group A)
Trial: 11270027
Drug: 1.0 mL
RxNorm normalized name: digoxin 0.25 mg in 1.0 mL INTRAVENOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mL 1% lidocaine (Group B)
Trial: 11270027
Drug: 1.0 mL
RxNorm normalized name: digoxin 0.25 mg in 1.0 mL INTRAVENOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mL dexamethasone (4 mg) (Group C)
Trial: 9266515
Drug: pravastatin (10-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pravastatin (10-40 mg/day)
Trial: 9266515
Drug: lovastatin (20-80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lovastatin (20-80 mg/day)
Trial: 3334238
Drug: Carbon fibre
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbon fibre augmentation
Trial: 3334238
Drug: Primary suture
RxNorm normalized name: Sodium primary phosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primary suture vs Carbon fibre augmentation
Trial: 22402617
Drug: SRP +
RxNorm normalized name: loratadine
DrugBank: Loratadine (DB00455)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SRP + DL (scaling, root planing, and diode laser treatment)
Trial: 2566251
Drug: Vecuronium 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium 0.1 mg kg‐1
Trial: 3351267
Drug: povidone‐iodine solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: povidone‐iodine solution
Trial: 27716209
Drug: Testosterone undecanoate
RxNorm normalized name: Testosterone Undecanoate
DrugBank: Testosterone undecanoate (DB13946)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone undecanoate (10-weekly intramuscular injections for 56 weeks)
Trial: 21353106
Drug: Pregabalin (150-600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin (150-600 mg/d)
Trial: 16680957
Drug: Combined FE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined FE enzymes (50 ml dissolved in 0‐150 ml normal saline to reach the final concentration of 1‐3 U/ml)
Trial: 9504644
Drug: Oestrogen monotherapy
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oestrogen monotherapy
Trial: 21828339
Drug: Insulin and
RxNorm normalized name: Isophane insulin and porcine regular insulin only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin and C-peptide response
Trial: 19126625
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg HPLC‐purified DHEA/d orally for 12 months
Trial: 17124720
Drug: DiaPep277 (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DiaPep277 (1 mg)
Trial: 9357387
Drug: Dapsone 100
RxNorm normalized name: dapsone 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapsone 100 mg
Trial: 7811056
Drug: Dapsone 100
RxNorm normalized name: dapsone 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapsone 100 mg with 30 ml high potency antacid
Trial: 2809052
Drug: Prompted voiding
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prompted voiding treatment (hourly checks, asking for toileting assistance, social reinforcement)
Trial: 2809052
Drug: Prompted voiding
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prompted voiding treatment
Trial: 31971279
Drug: Physiotherapy modalities
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Physiotherapy modalities (superficial heating and transcutaneous electrical nerve stimulation) and exercise therapy
Trial: 30585257
Drug: HD-FOLFIRI (irinotecan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HD-FOLFIRI (irinotecan dose 300 mg/m2 for UGT1A1*1/*1 and 260 mg/m2 for *1/*28)
Trial: 30585257
Drug: FOLFIRI (irinotecan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FOLFIRI (irinotecan dose 180 mg/m2)
Trial: 28243021
Drug: modified L‐haptic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: modified L‐haptic IOL
Trial: 24804018
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg Wellmune WGP(R) beta‐1,3/1,6‐Glucan daily for 4 weeks
Trial: 24804018
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg placebo (rice flour) daily for 4 weeks
Trial: 22068444
Drug: Daily sport
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily sport activity during the school day (1 hour of regulated sport exercise, including 15 min of endurance training, five days a week)
Trial: 22068444
Drug: Daily sport
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily sport activity during the school day
Trial: 19935991
Drug: Percutaneous adhesiolysis
RxNorm normalized name: PERCUTANEOUS INTRODUCER SET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percutaneous adhesiolysis with targeted delivery and injection of lidocaine, 10% hypertonic sodium chloride solution, and non‐particulate Betamethasone.
Trial: 19935991
Drug: Caudal epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal epidural injections with catheterization up to S3 with local anesthetic, 0.9% sodium chloride solution, non‐particulate betamethasone.
Trial: 15936866
Drug: Naltrexone (opiate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone (opiate antagonist)
Trial: 10636456
Drug: Subcutaneous enoxaparin
RxNorm normalized name: enoxaparin
DrugBank: Enoxaparin (DB01225)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous enoxaparin (40 mg once daily)
Trial: 2131899
Drug: Nicardipine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine administered at doses of 10 mg/h, 12.5 mg/h, and 15.0 mg/h for 5 minutes, 5 minutes, and 15 minutes, respectively.
Trial: 2131899
Drug: Nicardipine during
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine during maintenance period at an infusion rate reduced to 3.0 mg/h, adjusted by 1.0 to 2.5 mg/h every 15 minutes as needed.
Trial: 2131899
Drug: Baseline measurement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline measurement of plasma norepinephrine (NE) concentrations prior to nicardipine infusion.
Trial: 2131899
Drug: Nicardipine treatment.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine treatment.
Trial: 355601
Drug: Sodium valproate
RxNorm normalized name: sodium valproate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium valproate 1200 mg daily
Trial: 30878623
Drug: mHealth augmented
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mHealth augmented social support training (daily text-messages that synchronize with the patient messages)
Trial: 24273967
Drug: Chinese medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese medical treatment (Shen invigorating and blood activating, Shen invigorating and Pi supplementing, Shen‐qi benefiting)
Trial: 24273967
Drug: Western medical
RxNorm normalized name: Western wheatgrass
DrugBank: Pascopyrum smithii pollen (DB10719)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medical treatment (Clomifene, 25 mg per day)
Trial: 21574782
Drug: 400 IU
RxNorm normalized name: Vitamin D 400 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 IU cholecalciferol by dropper (1 mL syrup)
Trial: 16723246
Drug: Intermittent antegrade
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent antegrade cold crystalloid (CC)
Trial: 11216500
Drug: Wheat bran
RxNorm normalized name: Wheat bran
DrugBank: Wheat bran (DB10685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wheat bran biscuit (7.5 g/day) for 12 weeks
Trial: 11216500
Drug: Wheat bran
RxNorm normalized name: Wheat bran
DrugBank: Wheat bran (DB10685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wheat bran biscuit (15 g/day) for 12 weeks
Trial: 4038159
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil supplement (15 g daily for 4 weeks)
Trial: 4038159
Drug: Vegetable oil
RxNorm normalized name: Vegetable Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vegetable oil supplement (15 g daily for 4 weeks)
Trial: 28729021
Drug: Ceritinib 600
RxNorm normalized name: Ceritinib
DrugBank: Ceritinib (DB09063)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ceritinib 600 mg with food
Trial: 24301237
Drug: Full-face injections
RxNorm normalized name: bald-faced hornet venom protein Injectable Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full-face injections of abobotulinum toxin A (ABO) at doses of 120-165 U
Trial: 24301237
Drug: Full-face injections
RxNorm normalized name: bald-faced hornet venom protein Injectable Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full-face injections of abobotulinum toxin A (ABO) at doses of 166-205 U
Trial: 24301237
Drug: Full-face injections
RxNorm normalized name: bald-faced hornet venom protein Injectable Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full-face injections of abobotulinum toxin A (ABO) at doses of 206-250 U
Trial: 22080324
Drug: Betaine (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betaine (2.5 g mixed in 500 ml of Gatorade®)
Trial: 22080324
Drug: Placebo (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (500 ml of Gatorade®)
Trial: 14691990
Drug: 18-g needle
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 18-g needle
Trial: 14691990
Drug: 20-mL syringe
RxNorm normalized name: thiopental
DrugBank: Thiopental (DB00599)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 20-mL syringe
Trial: 14691990
Drug: 20-g needle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20-g needle
Trial: 30580488
Drug: 5-mL syringe
RxNorm normalized name: poliovirus vaccine inactivated, type 1 (Mahoney)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-mL syringe
Trial: 11425979
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of PPP and PVP imaging
Trial: 30358109
Drug: Golimumab (anti-TNF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Golimumab (anti-TNF antibody)
Trial: 30358109
Drug: Mavrilimumab (GM-CSF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mavrilimumab (GM-CSF receptor antibody)
Trial: 28546090
Drug: Cabotegravir (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabotegravir (800 mg intramuscular injections every 12 weeks)
Trial: 28546090
Drug: Placebo (saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (saline injections every 12 weeks)
Trial: 28546090
Drug: Cabotegravir (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabotegravir (800 mg intramuscular injections)
Trial: 21190995
Drug: Partly self-administered
RxNorm normalized name: corticotropin
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Partly self-administered exercise intervention
Trial: 17005076
Drug: Chemotherapy combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy combined with Chinese medicine (Synthetic group)
Trial: 1898697
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone therapy (0.2 mg/kg per day)
Trial: 1898697
Drug: Hyperinsulinemic clamp
RxNorm normalized name: CLAMP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperinsulinemic clamp (insulin concentration > 1435 pmol/L)
Trial: 6849746
Drug: i.v. nicardipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. nicardipine (0.5-20 mg)
Trial: 6849746
Drug: Oral nicardipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral nicardipine (10-40 mg)
Trial: 2792112
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg nicardipine
Trial: 30859995
Drug: AR19 (20-mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AR19 (20-mg capsule)
Trial: 30859995
Drug: Reference (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference (2 x 10-mg tablets)
Trial: 17909087
Drug: Vildagliptin 100
RxNorm normalized name: vildagliptin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vildagliptin 100 mg once daily for 6 weeks
Trial: 8720432
Drug: Atrial natriuretic
RxNorm normalized name: Atrial natriuretic factor
DrugBank: Atrial natriuretic peptide (DB15591)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atrial natriuretic factor (ANF) infusion at 1, 10, and 100 ng/min/dl forearm volume
Trial: 8720432
Drug: Atrial natriuretic
RxNorm normalized name: Atrial natriuretic factor
DrugBank: Atrial natriuretic peptide (DB15591)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atrial natriuretic factor (ANF) infusion
Trial: 1505903
Drug: Total parenteral
RxNorm normalized name: TPN - total parenteral nutrition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total parenteral nutrition (PN)
Trial: 1633010
Drug: Total parenteral
RxNorm normalized name: TPN - total parenteral nutrition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total parenteral nutrition (PN) plus biosynthetic human growth hormone (bGH) 4 UI/daily
Trial: 3534588
Drug: One cycle
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One cycle of CMF chemotherapy (cyclophosphamide, methotrexate, and 5-fluorouracil) preoperatively
Trial: 3534588
Drug: Postoperative adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative adjuvant chemotherapy (not specified in detail)
Trial: 22033034
Drug: Intravenous (IV)
RxNorm normalized name: intravenous (IV) infusion pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (IV) chemotherapy with cisplatin/paclitaxel
Trial: 22033034
Drug: Intraperitoneal (IP)
RxNorm normalized name: Intraperitoneal Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraperitoneal (IP) chemotherapy with carboplatin followed by cisplatin/paclitaxel
Trial: 22033034
Drug: Patients with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients with low pre-chemotherapy CA125 levels
Trial: 19039946
Drug: Impaza (superlow-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Impaza (superlow-dose antibodies to endothelial NO synthase)
Trial: 12775314
Drug: Clobetasone butyrate
RxNorm normalized name: clobetasone butyrate
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Clobetasone butyrate 0.05% cream
Trial: 8911885
Drug: Sodium tiludronate
RxNorm normalized name: tiludronate
DrugBank: Tiludronic acid (DB01133)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium tiludronate 200 mg
Trial: 8911885
Drug: Sodium tiludronate
RxNorm normalized name: tiludronate
DrugBank: Tiludronic acid (DB01133)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium tiludronate 400 mg
Trial: 8911885
Drug: Sodium tiludronate
RxNorm normalized name: tiludronate
DrugBank: Tiludronic acid (DB01133)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium tiludronate 600 mg
Trial: 8911885
Drug: Sodium tiludronate
RxNorm normalized name: tiludronate
DrugBank: Tiludronic acid (DB01133)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium tiludronate 800 mg
Trial: 7125264
Drug: Midazolam (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.3 mg/kg)
Trial: 3731680
Drug: Diazepam (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (0.3 mg/kg)
Trial: 4059300
Drug: Thiopentone (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopentone (5 mg/kg)
Trial: 9702844
Drug: Diphenhydramine 25
RxNorm normalized name: DIPHENHYDRAMINE 25MG CHEW TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphenhydramine 25 mg
Trial: 21159473
Drug: Midazolam 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 1.5 mg
Trial: 20565296
Drug: Placebo (vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (vitamin B injections)
Trial: 11766999
Drug: Amitriptyline (75-150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (75-150 mg/day)
Trial: 7934151
Drug: Terbutaline via
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline via Turbuhaler (1.0 mg)
Trial: 7934151
Drug: Terbutaline via
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline via Turbuhaler (2.5 mg)
Trial: 7934151
Drug: Terbutaline via
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline via CFC inhaler (1.0 mg without Nebuhaler)
Trial: 7934151
Drug: Terbutaline via
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline via CFC inhaler (2.5 mg with Nebuhaler)
Trial: 3073868
Drug: Interferon (Wellferon)
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon (Wellferon) at doses of 5 MU/m2 i.m. daily for the first 4 weeks and three times weekly for 5 months thereafter
Trial: 30553700
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of RG7800
Trial: 21114770
Drug: Bupropion-SR 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupropion-SR 150 mg/day for 2 months
Trial: 7700071
Drug: Cilazapril (2.5-5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilazapril (2.5-5 mg, once daily for 12 weeks)
Trial: 7700071
Drug: Nitrendipine (10-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrendipine (10-20 mg, once daily for 12 weeks)
Trial: 2607127
Drug: Lofepramine (140
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lofepramine (140 mg)
Trial: 31853543
Drug: Machine Learning
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Machine Learning (ML)
Trial: 30075596
Drug: Electrophysiological study
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Electrophysiological study (ES) positive, treated by catheter ablation and/or device implants
Trial: 30075596
Drug: Electrophysiological study
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Electrophysiological study (ES) negative, no interventional treatment
Trial: 27206810
Drug: Hydralazine/isosorbide dinitrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydralazine/isosorbide dinitrate (HYIS) 50 mg/20 mg t.i.d. for 24 weeks
Trial: 25782469
Drug: 2.25 g
RxNorm normalized name: Zosyn 2.25 GM Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.25 g SMO.IR and placebo alcohol preparation
Trial: 25782469
Drug: 2.25 g
RxNorm normalized name: Zosyn 2.25 GM Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.25 g SMO.IR and alcohol
Trial: 25782469
Drug: 2.25 g
RxNorm normalized name: Zosyn 2.25 GM Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.25 g SMO.IR matching placebo and alcohol
Trial: 25782469
Drug: 2.25 g
RxNorm normalized name: Zosyn 2.25 GM Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.25 g SMO.IR matching placebo and placebo alcohol preparation
Trial: 23453866
Drug: AGE-S (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AGE-S (250 mg aged garlic extract, 100 μg vitamin B12, 300 μg folic acid, 12.5 mg vitamin B6, 100 mg L-arginine)
Trial: 19640315
Drug: Intratympanic methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intratympanic methylprednisolone injections
Trial: 2533450
Drug: Danazol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danazol (200 mg three times a day)
Trial: 2526031
Drug: High-dose medroxyprogesterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose medroxyprogesterone acetate (100 mg a day)
Trial: 2526031
Drug: Danazol and
RxNorm normalized name: Danazol
DrugBank: Danazol (DB01406)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Danazol and high-dose MPA
Trial: 925164
Drug: Rational (cognitive)
RxNorm normalized name: plasma protein fraction Injection [Plasmanate]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rational (cognitive) restructuring treatment
Trial: 31586772
Drug: Melatonin 25
RxNorm normalized name: calcium phosphate/melatonin 250 mg-1.5 mg ORAL TABLET,CHEWABLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin 25 mg
Trial: 31101403
Drug: Bexagliflozin, 20mg,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bexagliflozin, 20mg, daily for 24 weeks
Trial: 22422736
Drug: 3-drug chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-drug chemotherapy (including doxorubicin) with or without lung radiation
Trial: 22422736
Drug: 2-drug chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-drug chemotherapy (dactinomycin and vincristine)